Morgan Stanley Dr Reddys Laboratories LTD Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Morgan Stanley holds 4,854,849 shares of RDY stock, worth $71.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,854,849
Previous 8,736,296
44.43%
Holding current value
$71.5 Million
Previous $115 Million
36.68%
% of portfolio
0.0%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding RDY
# of Institutions
262Shares Held
92.3MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.13.1MShares$193 Million0.27% of portfolio
-
Royal Bank Of Canada Toronto, A69.96MShares$147 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.01MShares$133 Million0.19% of portfolio
-
Aikya Investment Management LTD London, X06.35MShares$93.6 Million28.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.4MShares$79.5 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.45B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...